Literature DB >> 28279489

Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: The PROCRID study.

Antonio Gutiérrez-Pizarraya1, Luis Martín-Villén2, Luis Alcalá-Hernández3, Mercedes Marín Arriaza3, Bárbara Balandín-Moreno4, César Aragón-González5, José Ferreres-Franco6, Miguel Ángel Chiveli Monleón7, Paloma Anguita-Alonso8, Emilio Bouza-Santiago3, José Garnacho-Montero9.   

Abstract

INTRODUCTION: Our objectives were to describe the incidence, clinical characteristics, and risk factors for Clostridium difficile infection (CDI) in critically ill patients and to determine C. difficile PCR-ribotypes.
METHODS: Prospective, observational study in 26 Spanish ICUs. Patients with diarrhea meeting ESCMID criteria for CDI were included. Molecular characterization of isolates was performed using PCR ribotyping.
RESULTS: Of 4258 patients admitted to the ICUs, 190 (4.5%) developed diarrhea. Only 16 patients (8.4%) were diagnosed with CDI. Ribotype 078/126 (25.0%) was the most frequently identified. The mortality rate was similar in patients with ICD compared to patients with diarrhea not caused by C. difficile (p=0.115). Chronic renal insufficiency was identified as the only factor independently associated with the development of CDI (OR 5.87, 95% CI 1.24-27.83; p=0.026).
CONCLUSIONS: The incidence of CDI in Spanish ICUs is low. Only chronic renal insufficiency was observed to be a risk factor for CDI development.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; ICU; Incidence; Incidencia; Mortalidad; Mortality; UCI

Mesh:

Year:  2017        PMID: 28279489     DOI: 10.1016/j.eimc.2017.01.007

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  1 in total

Review 1.  Critical Care Management of the Patient with Clostridioides difficile.

Authors:  Max W Adelman; Michael H Woodworth; Virginia O Shaffer; Greg S Martin; Colleen S Kraft
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.